Claro Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$350K Buy
2,291
+196
+9% +$30K 0.04% 332
2025
Q4
$289K Sell
2,095
-41
-2% -$5.37K 0.04% 332
2025
Q3
$274K Sell
2,136
-74
-3% -$9.03K 0.04% 333
2025
Q2
$267K Buy
2,210
+91
+4% +$10.3K 0.04% 317
2025
Q1
$236K Sell
2,119
-1,835
-46% -$195K 0.03% 442
2024
Q4
$385K Sell
3,954
-684
-15% -$72.9K 0.05% 296
2024
Q3
$533K Buy
+4,638
New +$526K 0.07% 258
2022
Q4
Sell
-4,695
Closed -$397K 344
2022
Q3
$397K Hold
4,695
0.16% 154
2022
Q2
$397K Buy
4,695
+1,828
+64% +$160K 0.16% 154
2022
Q1
$251K Hold
2,867
0.09% 225
2021
Q4
$251K Sell
2,867
-77
-3% -$6.39K 0.09% 225
2021
Q3
$241K Buy
2,944
+243
+9% +$21.9K 0.1% 211
2021
Q2
$246K Sell
2,701
-1
-0% -$89 0.11% 195
2021
Q1
$231K Buy
2,702
+190
+8% +$17.1K 0.12% 186
2020
Q4
$237K Sell
2,512
-668
-21% -$58.4K 0.13% 181
2020
Q3
$277K Buy
3,180
+107
+3% +$9.27K 0.18% 147
2020
Q2
$268K Buy
3,073
+301
+11% +$26K 0.18% 141
2020
Q1
$229K Buy
2,772
+289
+12% +$25.8K 0.21% 137
2019
Q4
$235K Buy
2,483
+44
+2% +$3.95K 0.18% 141
2019
Q3
$212K Buy
2,439
+65
+3% +$5.84K 0.19% 150
2019
Q2
$217K Sell
2,374
-366
-13% -$31K 0.2% 144
2019
Q1
$236K Buy
2,740
+1,127
+70% +$90.5K 0.23% 127
2018
Q4
$125K Buy
+1,613
New +$126K 0.1% 187

Other funds holding NVS

Claro Advisors's NVS Position: Q1 2026 in Review

Claro Advisors increased its Novartis (NVS) stake by 9.4% in Q1 2026, buying an estimated $30K and bringing the position to 2,291 shares worth $350K. The position accounts for 0.04% of the portfolio, ranked #332.

Claro Advisors first reported a position in NVS in Q4 2018 and has held it in 23 quarters since. The position peaked at $533K in Q3 2024. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Claro Advisors held 2,291 shares of Novartis worth $350K as of Q1 2026.
  • Claro Advisors bought 196 Novartis shares in Q1 2026, an estimated $30K.
  • Novartis made up 0.04% of Claro Advisors's portfolio in Q1 2026, its #332 holding.
  • Claro Advisors first reported a position in Novartis in Q4 2018 and has held it in 23 quarters since.
  • Claro Advisors's Novartis position peaked at $533K in Q3 2024.
  • 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Claro Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.